CM
IRWD icon

Cercano Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cercano Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Hold
101,378
– – 0.02% 108
2025
Q4 		$342K Hold
101,378
– – 0.01% 115
2025
Q3 		$133K Hold
101,378
– – 0.01% 151
2025
Q2 		$72.7K Hold
101,378
– – ﹤0.01% 150
2025
Q1 		$149K Hold
101,378
– – ﹤0.01% 146
2024
Q4 		$449K Hold
101,378
– – 0.01% 133
2024
Q3 		$418K Buy
+101,378
New +$545K 0.01% 117

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cercano Management's IRWD Position: Q1 2026 in Review

Cercano Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 101,378 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #108.

Cercano Management first reported a position in IRWD in Q3 2024 and has held it in 7 quarters since. The position peaked at $449K in Q4 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Cercano Management held 101,378 shares of Ironwood Pharmaceuticals worth $356K as of Q1 2026.
  • Cercano Management left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.02% of Cercano Management's portfolio in Q1 2026, its #108 holding.
  • Cercano Management first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Cercano Management's Ironwood Pharmaceuticals position peaked at $449K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Cercano Management's 13F filing for Q1 2026, filed 13 May 2026.